Support DPI drug development programs by (1) developing and validating sensitive and bioanalytical methods to quantify concentrations of novel biologics; (2) developing assays for measurement of…
Active Awarded Last action
- Contract number
- HHSN271201800007I
- Awardee
-
PPD Development LP UEI ZANENSW6C665
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $347,500 obligated
Award facts
- Opportunity
-
- N01TR172004 Solicitation number
- CRO Support for NCATS Bioanalytical Method Development for Biologics Award Notice · Posted Jan 11, 2017
- Combined order value
- $347,500 Current and potential, with all options
- Last date to order 95% complete
- IDV ceiling 9% used
- $3,912,150.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization (CRO). The contract has a total potential value of $3,912,150 and provides comprehensive, integrated drug development, laboratory, and lifecycle management services to support NCATS' bioanalytical method development programs. This includes developing and validating sensitive bioanalytical methods to quantify novel biologic concentrations, developing assays to measure anti-drug antibodies, and providing general bioanalytical support for drug concentration and anti-drug antibody measurement.
Under a $347,500 firm fixed price delivery order issued in 2018, PPD is supporting NCATS' drug development programs in areas such as regulatory management, clinical trial monitoring, data management, and analytical testing services. The contract does not have a set-aside designation and the period of performance extends through March 2027. This NCATS IDC leverages PPD's extensive experience as a prime contractor across HHS, DoD, and other agencies, providing over $500 million in clinical research and development services to support vaccine, therapeutic, and medical countermeasures programs.
Description
Support DPI drug development programs by (1) developing and validating sensitive and bioanalytical methods to quantify concentrations of novel biologics; (2) developing assays for measurement of anti-drug antibodies; and (3) providing bioanalytical support for drug concentration and antidrug antibody measurement.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| PPD development LP:1106692 [18-007540] | National Institute on Drug Abuse (NIH) | $347,500 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | -$5,000 | |
| Original award | $5,000 |
Quick answers
Who was awarded contract HHSN271201800007I?
HHSN271201800007I was awarded to PPD Development LP by National Institute on Drug Abuse (National Institutes of Health) on March 26, 2018.
How much is contract HHSN271201800007I worth?
Orders under HHSN271201800007I have obligated $347,500. HHSN271201800007I's own ceiling is $3,912,150.
How many orders have been placed under contract HHSN271201800007I?
1 order has been placed under HHSN271201800007I, the latest on September 24, 2018.
Which agency awarded contract HHSN271201800007I?
National Institute on Drug Abuse (National Institutes of Health) awarded HHSN271201800007I, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Who can order from contract HHSN271201800007I?
HHSN271201800007I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN271201800007I part of a contract vehicle?
Yes. HHSN271201800007I is part of CRO Support for NCATS Bioanalytical Method Development.
Was contract HHSN271201800007I competed?
The extent of competition for HHSN271201800007I was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV